Filter
2034
Filtered Results: 2034
Text search:
national
immunization
coverage
Featured
Recommendations
157
New Publications
717
Language
Document type
No document type
1248
Studies & Reports
320
Guidelines
195
Strategic & Response Plan
108
Manuals
84
Fact sheets
27
Situation Updates
25
Training Material
17
Resource Platforms
5
Infographics
3
Brochures
2
Countries / Regions
India
116
Kenya
98
Global
86
Nepal
69
Nigeria
60
Sierra Leone
59
Uganda
59
Ethiopia
52
Liberia
52
South Africa
50
Myanmar / Burma
49
Bangladesh
47
Zambia
41
Ghana
38
Rwanda
37
Malawi
35
Africa
34
Tanzania
29
Latin America and the Carribbean
27
Lesotho
23
Congo, Democratic Republic of
23
Philippines
22
Cambodia
21
Namibia
21
Indonesia
21
Zimbabwe
20
Western and Central Europe
18
Pakistan
18
Ukraine
17
Mozambique
17
Syria
16
Botswana
16
Guinea
14
East and Southern Africa
14
South–East Asia Region
13
South Sudan
13
Senegal
12
Afghanistan
12
Brazil
10
Asia
9
West and Central Africa
9
Yemen
9
Burkina Faso
8
Haiti
8
Venezuela
8
Middle East and North Africa
7
Sudan
7
Central African Republic
7
Eswatini/ Swaziland
6
Colombia
5
Cameroon
5
Germany
5
Western Pacific Region
5
Lebanon
5
Somalia
5
Chile
4
Albania
4
Eastern Europe and Central Asia
4
Eastern Europe
4
Papua New Guinea
4
Mali
4
Paraguay
3
Iraq
3
Madagascar
3
Timor Leste/ East Timor
2
Mexico
2
China
2
Laos
2
Niger
2
Burundi
2
Peru
2
Jordan
2
Turkmenistan
2
Southern Africa
2
Bolivia
2
Argentina
2
Moldova
2
Sri Lanka
2
Russia
2
Egypt
2
Palestine
2
Angola
2
Libya
2
Ecuador
2
Tajikistan
1
Thailand
1
Turkey
1
Benin
1
Togo
1
Iran
1
Singapore
1
Qatar
1
Bulgaria
1
USA
1
Saudi Arabia
1
Japan
1
Maldives
1
Mauritius
1
Côte d’Ivoire / Ivory Coast
1
Djibouti
1
Georgia
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
1081
Clinical Guidelines
152
Public Health
136
Women & Child Health
131
Key Resources
95
Capacity Building
17
Pharmacy & Technologies
6
Toolboxes
COVID-19
194
HIV
82
Rapid Response
66
TB
59
AMR
59
Conflict
52
Caregiver
46
Polio
42
Global Health Education
40
Ebola & Marburg
37
Health Financing Toolbox
37
NTDs
32
Refugee
31
Mental Health
25
Disability
25
Natural Hazards
22
Pharmacy
18
Planetary Health
16
NCDs
12
Cholera
11
Malaria
3
Zika
3
Specific Hazards
2
South Sudan
1
Typhoon
1
The focus of the current quarterly edition of Eurohealth (from the European Observatory on Health Systems and Policies) is Antimicrobial Resistance (AMR) and contains the following articles:
• Strengthening implementation of AMR national action plans
• Fostering clinical developmen...
In recent years, Rwanda has been on the fast track to achieve major health improvements for its entire population. With the support of government agencies and various non-governmental partners, the Ministry of Health (MoH) has endeavored to decentralize Rwanda’s health system and bring health serv...
Human rabies remains a significant public health problem in Africa with outbreaks reported in most countries. In Nigeria–the most populous country in Africa–rabies causes a significant public health burden partly due to perennial obstacles to implementing a national prevention and control progra...
Community health worker teams are potential game-changers in ensuring access to care in vulnerable communities. Who are they? What do they actually do? Can they help South Africa realize universal health coverage? As the proactive arm of the health services, community health workers teams provide ho...
The 2021 COVID-19 Strategic Preparedness and Response Plan (SPRP) for AFR serves as a regional guide for a holistic public health response to COVID‑19 at regional, national and sub-national levels. The 2021
SPRP:
1. Builds upon the lessons learnt from the implementation of the 2020 SPRP and outl...
Improving the survival chances and quality of life of women, newborns, and children remains an urgent global challenge. Since 2012, substantial progress has been made in reducing maternal and under-5 deaths, and a only handful of countries are on target to meet the SDG targets in 2030. Yet, 5 millio...
The guide aims to provide health and DRM practitioners, planners and policymakers across sectors with targeted information to help them strengthen national health systems and integrate the risks of disease outbreaks in national DRR strategies
The following are some of the principles and approache...
The 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic public funding and declining external financing. T...
Following the high-level meeting of the UN General Assembly on antimicrobial resistance held in September 2016 which called for national, regional and international political commitment to address the issue, member countries agreed on the importance of moving forward to develop national action plans...
This Community Health Systems (CHS) Catalog country profile is the 2016 update of a landscape
assessment that was originally conducted by the Advancing Partners & Communities (APC) project
in 2014. The CHS Catalog focuses on 25 countries deemed priority by the United States Agency for
Internation...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
This catalogue provides tools and information resources to support EU/EEA countries in addressing the challenging issue of vaccine hesitancy. The catalogue provides examples of practices that can serve as a resource for other countries. The project was developed in the context of ECDC’s support fo...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
14 de setembro de 2020Este Modelo de Valores fornece orientações globais para alocação de vacinas contra a COVID-19 entre os países, e orientações nacionais de priorização de grupos para vacinação dentro dos países em caso de oferta limitada. O Modelo destina-se a auxiliar os elaboradore...
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immunization; (iii) palliative care in lowresource settings; (iv) risk assessment to guide management of bite...
A key purpose of the Recovery Toolkit is to support countries in the reactivation of health services which may have suffered as a result of the emergency. These services include ongoing programmes such as immunization and vaccinations, maternal and child health services, and noncommunicable diseases...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...
Available in English, French, Portuguese and Arabic
Successful immunization of a critical mass of the African population with one or several safe and efficacious COVID-19 vaccines.Key objectives1. Accelerate African involvement in the clinical development of a vaccine. 2. Ensur...
